Trials / Completed
CompletedNCT05916521
A Three Month Bleeding-Model Clinical Study
A Three-Month Bleeding-Model Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to evaluate the gingivitis control benefit of an established stannous fluoride containing toothpaste relative to a negative control dentifrice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.454% stannous fluoride | Brush two times daily |
| DRUG | 0.76% sodium monofluorophosphate | Brush two times daily |
| DRUG | 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM | Brush two times daily |
Timeline
- Start date
- 2021-11-15
- Primary completion
- 2022-02-11
- Completion
- 2022-02-11
- First posted
- 2023-06-23
- Last updated
- 2023-06-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05916521. Inclusion in this directory is not an endorsement.